Position in PFE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$6,824,320
-$1,042,965 QoQ
Shares Held
283,402
+1.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#514
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EVERETT HARRIS & CO /CA/ holds $616,457,307 across 12 Drug Manufacturers - General names. PFE ranks #7 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
6,475,622 | $310,441,318 | |
| 2 | ABBV |
AbbVie Inc.
|
512,541 | $128,975,817 | |
| 3 | JNJ |
Johnson & Johnson
|
469,392 | $119,211,486 | |
| 4 | MRK |
Merck & Co., Inc.
|
221,036 | $28,403,126 | |
| 5 | LLY |
ELI LILLY & Co
|
8,557 | $10,263,523 | |
| 6 | AMGN |
Amgen Inc
|
23,296 | $8,435,947 | |
| 7 | PFE |
Pfizer Inc
This page
|
283,402 | $6,824,320 | |
| 8 | NVS |
Novartis AG
|
17,363 | $2,721,129 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,824,320 | 283,402 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $7,867,285 | 280,174 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $6,714,658 | 269,665 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $6,838,322 | 268,380 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $6,477,703 | 267,232 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $5,999,523 | 236,761 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $5,949,432 | 224,253 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $6,318,875 | 218,344 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $5,021,682 | 179,474 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $4,016,035 | 144,722 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $3,394,628 | 117,910 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $3,919,698 | 118,170 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $4,331,064 | 118,077 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $4,643,162 | 113,803 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $5,814,356 | 113,473 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $6,375,788 | 145,699 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $7,542,265 | 143,854 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $7,050,400 | 136,187 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $8,036,232 | 136,092 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $5,800,844 | 134,872 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $4,956,363 | 126,567 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $4,291,298 | 118,446 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,106,192 | 111,551 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $3,950,237 | 107,636 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $3,408,815 | 104,245 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $3,313,020 | 101,502 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||